Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination therapies for cancer: challenges and opportunities
Zhijun Zhou, Barish H. Edil, Min Li
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 19
A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance
Jing Zhou, Nan Lyu, Qiongling Wang, et al.
Cancer Letters (2023) Vol. 578, pp. 216457-216457
Open Access | Times Cited: 27
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy
Madhu Kamle, Shikha Pandhi, Sadhna Mishra, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 9
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
Vojtěch Novohradský, Tomer Babu, Hana Kostrhunová, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117854-117854
Closed Access | Times Cited: 1
Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings
Deepa Sharma, Gregory J. Czarnota
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5
Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies
Carolina Sousa, Mafalda Videira
Onco (2025) Vol. 5, Iss. 1, pp. 2-2
Open Access
Design, Synthesis and Evaluation of Diarylidenyl Piperidone-Ligated Platinum (IV) Complexes as Chemoimmunotherapeutic Agents
Zhi-Chen Mao, Lei Chen, Xiao-Man Chen, et al.
European Journal of Medicinal Chemistry (2025), pp. 117338-117338
Closed Access
Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer
Yumeng Hu, Yifu Hu, Shaobo Zhang, et al.
Cancer Letters (2025) Vol. 614, pp. 217523-217523
Closed Access
Pentose Phosphate Recycling driven by Gli1 contributes to chemotherapy resistance in Cancer Cells
Qiangsheng Hu, Cheng Jiang, Yi Qin, et al.
Cancer Letters (2025), pp. 217633-217633
Closed Access
Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study
Fawziya A. R. Ibrahim, Neveen A. Hussein, Aisha Y. M. Soliman, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Open Access | Times Cited: 3
Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells
Mahima Verma, Shireen Fatima, Mοhd Saeed, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Development of 5-fluorouracil/etoposide co-loaded electrospun nanofibrous scaffold for localized anti-melanoma therapy
Shirin Shojaei, Mahtab Doostan, Hamid-Reza Mohammadi Motlagh, et al.
Journal of Applied Biomaterials & Functional Materials (2024) Vol. 22
Open Access | Times Cited: 3
Advancing non-small cell lung cancer treatment: the power of combination immunotherapies
Yuanlin Wu, Guangmao Yu, Ketao Jin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Combinatory Effect of Pequi Oil (Caryocar brasiliense)-Based Nanoemulsions Associated to Docetaxel and Anacardic Acid (Anacardium occidentale) in Triple-Negative Breast Cancer Cells In Vitro
Alicia S. Ombredane, Natália Ornelas Martins, Gabriela Mara Vieira de Souza, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1170-1170
Open Access | Times Cited: 1
GDF15 and LCN2 for early detection and prognosis of pancreatic cancer
Xinxia Zhu, Brennan Olson, Dove Keith, et al.
Translational Oncology (2024) Vol. 50, pp. 102129-102129
Open Access | Times Cited: 1
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases
Kexin Zhao, Yangqing Sun, Shangwei Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing
Karim S. Shalaby, Sathvik Guru Rao, Bruce Schultz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Preclinical study of TLR stimulation combined PD-1 antibody enhance the therapeutic effect of microwave ablation on NSCLC
Ying Yu, Fu Niu, Bo Sun, et al.
Clinical & Translational Oncology (2024)
Closed Access
Identification of a distinct tumor endothelial cell-related gene expression signature associated with patient prognosis and immunotherapy response in multiple cancers
Xianhua Zhuo, Cheng Huang, Liangping Su, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 9635-9655
Closed Access | Times Cited: 1
Page 1

Scroll to top